- Venture watch
- Posts
- Upstate Capital congratulates CNY Biotech Accelerator
Upstate Capital congratulates CNY Biotech Accelerator
"Repair Biotechnologies Achieves Significant Milestone in Liver Fibrosis Reduction"
Upstate Capital Association of New York congratulates CNY Biotech Accelerator and Upstate Medical University client company, Repair Biotechnologies, on achieving a remarkable 44% reduction in measures of liver fibrosis.
Repair Biotechnologies specializes in developing gene therapies based on its proprietary Cholesterol Degrading Platform (CDP), which safely breaks down excess free cholesterol inside cells.
For full details, refer to the press release linked below: https://lnkd.in/e_dmt9SD